Results 341 to 350 of about 116,711 (370)

Effect of glucagon‐like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta‐analysis

Clinical Obesity, EarlyView.
Summary The effect of glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) on systolic blood pressure (SBP) in patients with obesity with or without diabetes remains unclear. The aim was to compare the effect of different drug–dose combinations of GLP‐1RAs on SBP.
Abraish Ali, Asad Ali Siddiqui, Muhammad Shariq Usman, Izza Shahid, Muhammad Shahzeb Khan, Prinka Perswani   +5 more
wiley   +1 more source

Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2. [PDF]

J Endocr Soc
Davis WA, Chakera A, Chubb SAP, Davis TME.   +3 more
europepmc   +1 more source

Lactate and Lactylation in AKI‐to‐CKD: Epigenetic Regulation and Therapeutic Opportunities

Cell Proliferation, EarlyView.
ABSTRACT Lactate is not only a byproduct of glycolysis, but is also considered an energy source, gluconeogenic precursor, signalling molecule and protein modifier during the process of cellular metabolism. The discovery of lactylation reveals the multifaceted functions of lactate in cellular metabolism and opens new avenues for lactate‐related research.
Yi Hou, Dongwei Liu, Zuishuang Guo, Cien Wei, Fengyu Cao, Yue Xu, Qi Feng, Fengxun Liu   +7 more
wiley   +1 more source

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease. [PDF]

Cardiovasc Diabetol
Felício JS, Araújo MAM, de Lemos GN, Fernandes IJ, Ruivo LO, Chambouleyron EDG, de Souza D'Albuquerque Silva L, Nunes CF, de Andrade Paes GM, de Melo FTC, Piani PPF, Motta ARB, Leal VSG, de Souza ACCB, de Queiroz NNM, Dos Santos MC, Felício KM, de Figueiredo PAB.   +17 more
europepmc   +1 more source

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: a commentary from the European Renal Best Practice (ERBP). [PDF]

Nephrol Dial Transplant
Iatridi F, Carrero JJ, Gall EC, Kanbay M, Luyckx V, Shroff R, Ferro CJ.   +6 more
europepmc   +1 more source

Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport. [PDF]

Nephrol Dial Transplant
Gross O, Boeckhaus J, Weber LT, Heerspink HJL, Simon JF, Ahmed R, Gerst C, Duerr U, Walker F, Tostmann R, Helm J, Asendorf T, Friede T, study group of the German Society of Pediatric Nephrology .   +13 more
europepmc   +1 more source

Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA1c reliability

Diabetic Medicine, EarlyView.
Abstract Aims HbA1c testing in African populations may be limited due to high prevalence of hemoglobinopathies, anaemia, malaria and renal impairment. We aimed to assess the performance of glycated albumin (GA) and fructosamine in comparison to HbA1c for determining glycaemic control in Africans living with type 2 diabetes.
Anxious J. Niwaha, Priscilla A. Balungi, Timothy J. McDonald, Andrew T. Hattersley, Beverley M. Shields, Moffat J. Nyirenda, Angus G. Jones   +6 more
wiley   +1 more source

Efficacy and safety of dapagliflozin in patients with CKD: real-world experience in 93 Italian renal clinics. [PDF]

Clin Kidney J
Minutolo R, Borrelli S, Ambrosini A, Amoroso L, Aucella F, Batini V, Battaglia Y, Bregoli L, Cantaluppi V, Cianciolo G, Conti P, Fabbrini P, Giammarresi C, Imbalzano E, La Rosa S, Marengo M, Montinaro V, Musone D, Napoli M, Nappi F, Pluvio C, Santoro D, Scarpioni R, Sopranzi F, Tullio T, De Nicola L.   +25 more
europepmc   +1 more source

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, Hiddo J. L. Heerspink, Ron T. Gansevoort   +4 more
wiley   +1 more source

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume III. [PDF]

Front Endocrinol (Lausanne)
Rando MM, Biscetti F, Flex A.
europepmc   +1 more source